<DOC>
	<DOC>NCT02598167</DOC>
	<brief_summary>This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.</brief_summary>
	<brief_title>Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<criteria>Participants aged greater than or equal to (&gt;/=) 18 years Participants who have a diagnosis of RRMS as documented in their medical records Participants who have been prescribed a DMT for at least 3 months Participants who have an expanded disability status scale (EDSS) score of 16 points Participants with any personal or medical condition that in opinion of the investigator would interfere with or make impossible proper participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>